BEHIND THE HEADLINES: Human embryo cloning PR battle hots up
30 Nov 2001 | by HOLLY WILLIAMS
. LIFE confirmed it immediately issued a press notice opposing the research and has since been placing ...
HEALTHCARE: Pharma giant Roche has handed Counsel a six-figure PR brief for market-leading indigestion treatment Rennie. The Huntsworth Group firm was appointed after a two-way pitch against incumbent Weber Shandwick Worldwide.
. LIFE confirmed it immediately issued a press notice opposing the research and has since been placing ...
Younger. Younger, who was unavailable for comment as PRWeek went to press, will take ...
Potter is to leave at the end of the month, handing over the role of senior vice-president, corporate communications and community partnerships to current IR boss Jennie Younger. Younger, who was unavailable for comment as PRWeek went to press, will take on responsibility for a team of 60 staff based ...
CONSUMER: Front Row PR has been taken on by Inspecs to promote the launch of daily contact lens range FCUK Daily. The French Connection brand extension aims to profit from what it claims is the comfort and convenience of daily lenses.
HEALTHCARE: Pharmaceutical giant Roche has hired Rebecca Hunt as PR manager for its specialist product portfolios, including cancer, HIV and kidney disease treatments. The firm has also taken on Shazia Sheikh as copywriter in its PR division.
relations department at gsk, but they don't have even the most basic functions for PR - not even a press ...
HEALTHCARE: Grayling Healthcare has been taken on to handle Abbott Laboratories' newly produced oral treatment for impotence. The product, called Uprima, is in tablet form and is set for launch later this year. Grayling associate director Glen Mursell heads the account.
, head of press at UK drugs giant AstraZeneca, adds: 'We still don't know the real detail about how it ...
HEALTHCARE: Pfizer has handed the PR account to promote its anti-depressant Lustral to Galliard Healthcare Communications. PR was previously carried out in-house. Galliard is already handling the UK pre-launch PR for the Pfizer anti-psychotic drug Ziprasidone.
Welcome to the first incarnation of a new element in Campaign in which we invite experts to burrow beneath the surface of the catch-all that is "digital". Google, Isobar Mobile, JWT London, LBI and MBA share their insights on mobile.